Docetaxel and cisplatin as first-line chemotherapy in advanced NSCLC.

被引：0
|
作者：
Behera, D [1 ]
Aggarwal, AN [1 ]
Gupta, D [1 ]
Jindal, SK [1 ]
Sharma, SC [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Chandigarh 160012, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：705S / 705S
页数：1
相关论文
共 50 条
  • [1] Effectiveness of docetaxel and cisplatin combination as first-line chemotherapy in advanced NSCLC
    Behera, D
    Aggarwal, A
    Gupta, D
    Jindal, S
    Aggarwal, R
    Sharma, S
    Kapoor, R
    LUNG CANCER, 2005, 49 : S389 - S389
  • [2] Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer
    Vasey, PA
    Paul, J
    Birt, A
    Junor, EJ
    Reed, NS
    Symonds, RP
    Atkinson, R
    Graham, J
    Crawford, SM
    Coleman, R
    Thomas, H
    Davis, J
    Eggleton, SPH
    Kaye, SB
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2069 - 2080
  • [3] First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Panopoulos, C
    Chrissohoou, M
    Apostolikas, N
    Efremidis, AP
    BREAST, 2005, 14 (02): : 136 - 141
  • [4] Nedaplatin plus Docetaxel versus Cisplatin plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung
    Lu, S.
    Chen, Z.
    Hu, C.
    Xin-Ling, R.
    Chen, Y.
    Song, Y.
    Qiong, Z.
    Fan, Y.
    Gang, W.
    Zhi-Yong, M.
    Fang, J.
    Qi-Tao, Y.
    Liu, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1807 - S1808
  • [5] The real-word evidence of first-line treatment of pembrolizumab in advanced NSCLC.
    Li, Pin
    Gadgeel, Shirish M.
    Poisson, Laila
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Phase II study of biweekly docetaxel and cisplatin combination chemotherapy in first-line advanced gastric cancer
    Quintero, G., Sr.
    Jorge, M.
    Casal, J.
    Salgado, M.
    Candamio, S.
    Lopez, R.
    Mel, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    Quintero-Aldana, G.
    Jorge, M.
    Grande, C.
    Salgado, M.
    Gallardo, E.
    Varela, S.
    Lopez, C.
    Villanueva, M. J.
    Fernandez, A.
    Alvarez, E.
    Gonzalez, P.
    Castellanos, J.
    Casal, J.
    Lopez, R.
    Campos Balea, B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 731 - 737
  • [8] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    G. Quintero-Aldana
    M. Jorge
    C. Grande
    M. Salgado
    E. Gallardo
    S. Varela
    C. López
    M. J. Villanueva
    A. Fernández
    E. Alvarez
    P. González
    J. Castellanos
    J. Casal
    R. López
    B. Campos Balea
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 731 - 737
  • [9] CISPLATIN AND DOCETAXEL AS FIRST LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Marrupe, D.
    Garcia, S.
    Lopez, E.
    Mendez, M.
    Quiben, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 112 - 113
  • [10] Capecitabine maintenance after first-line induction chemotherapy with docetaxel cisplatin, and fluorouracil in patients with advanced gastric cancer
    Oyan, Basak
    Eren, Orhan Onder
    Sonmez, Ozlem
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345